Cancer News and Research

Latest Cancer News and Research

Femtosecond-laser ablation of Xenopus melanocytes for studies of cell migration, wound repair

Using an ultrafast femtosecond laser, researchers at Tufts University in Medford, Mass., were able to label, draw patterns on, and remove individual melanocytes cells from a species of frog tadpole (Xenopus) without damaging surrounding cells and tissues.

19 Aug 2011

Antigen Express provides update on ongoing AE37 Phase 2 trial in breast cancer

Generex Biotechnology Corporation announced today that the Company's wholly-owned subsidiary Antigen Express, Inc. presented an update of the ongoing Phase 2 trial with an off-the-shelf immunotherapeutic cancer vaccine, AE37, in patients with breast cancer at Cambridge Healthtech Institute's Sixth Annual ImVacS: The Immunotherapeutics and Vaccine Summit held August 16-18, 2011 in Cambridge, MA.

19 Aug 2011

Women being screened too often for cervical cancer

Researchers based at the Centers for Disease Control and Prevention (CDC) found that many primary care doctors would bring women back for cancer screening annually - while recommendations generally call for a three-year wait after normal tests. This translates to higher costs to women and the healthcare system, as well as a risk of unnecessary treatment for false-positive test results - with very little additional cancer-catching benefit say experts. Lead author Katherine Roland said, “There's really no advantage to annual screening compared to screening every two or three years.”

18 Aug 2011

Medical research funding boost in UK

Health researchers in Cambridge have been awarded £114.5m to develop and translate new scientific discoveries into medicines and treatments. The funds come as a part of a five-year £800m investment by the National Institute for Health Research (NIHR).

18 Aug 2011

Australian youth mostly ignorant about sexual health

The survey found that most of the young people do not know about Pap smears, sexually transmitted infections and how the contraceptive pill works.

18 Aug 2011

First Edition: August 18, 2011

"The SSI program for children is rapidly expanding, with the biggest increase among kids with mental, behavioral and learning disorders, including ADHD, speech delays, autism, and bipolar disorder. But as it pulls in children like Hulston, the program is sparking criticism in Congress.

18 Aug 2011

Blocking pathway for generating energy can kill cancer cells

Cancer Research UK scientists have found that blocking the pathway used by some kidney cancer cells to generate energy can kill the cancer cells, sparing the healthy ones.

18 Aug 2011

EMA accepts Merck and ARIAD's MAA for ridaforolimus to treat metastatic bone sarcomas

Merck, known outside the United States and Canada as MSD, and ARIAD Pharmaceuticals, Inc., today announced that the European Medicines Agency (EMA) has completed its administrative validation process for the regulatory application for ridaforolimus, an investigational oral mTOR inhibitor developed for the treatment of metastatic soft-tissue or bone sarcomas in patients who had a favorable response to chemotherapy.

18 Aug 2011

Celgene expands share repurchase program

Celgene Corporation announced the Company's Board of Directors has authorized the repurchase of up to an additional $2 billion of the Company's common stock.

18 Aug 2011

New leukemia drug in early clinical testing offers some clues for better treatment

While testing a new drug designed to treat chronic leukemia, researchers at Cleveland Clinic discovered new markers that could identify which patients would receive maximum benefit from the treatment.

18 Aug 2011

U.S. research collaboration addresses threat of cancer in Latin America

In a post in the State Department's "DipNote" blog, Krysten Carrera, a Presidential Management fellow at the National Cancer Institute currently serving in the Bureau of International Organization Affairs, discusses "the growing international effort to address the threat of chronic non-communicable diseases."

18 Aug 2011

Premera, Cord Blood America partner to offer discount on stem cell collection services

Cord Blood America, Inc. today announced that it has entered into an agreement with Premera Blue Cross, a leading health plan provider with operations in Mountlake Terrace, Seattle and Spokane, Washington, and Anchorage, Alaska, and more than 1.4 million members, to store umbilical cord blood at a discounted rate consistent with other Blue Cross licensee contracts.

18 Aug 2011

Herbal supplements may weaken the effect of chemotherapy drugs

Acai berry, cumin, herbal tea, turmeric and long-term use of garlic - all herbal supplements commonly believed to be beneficial to your health - may negatively impact chemotherapy treatment according to a new report presented at the American Society of Clinical Oncology (ASCO) meeting in Chicago this summer.

18 Aug 2011

Advanced ROS selects RayStation for conventional 3D-CRT treatments

RaySearch Laboratories AB has received an order for its RayStation treatment planning system from Advanced Radiation Oncology Services in Nyack, New York.

18 Aug 2011

New process may eliminate need for full genome sequencing for cancer patients

People at risk for a certain form of colon and other types of cancer may soon have a better chance at surviving or even avoiding the diseases, thanks to a new study done by the Intermountain Clinical Genetics Institute at LDS Hospital.

18 Aug 2011

Medicare Advantage plans may be counter-productive for the elderly

In health care, more choice may not always lead to better choices, particularly for the elderly. In a new study, researchers from Harvard Medical School's Department of Health Care Policy found that the large variety of managed care plans offered by the Medicare Advantage program may be counter-productive.

18 Aug 2011

Majority of physicians continue to recommend annual cervical cancer screening

Investigators from the Centers for Disease Control and Prevention (CDC) have determined that the majority of primary care providers continue to recommend annual cervical cancer screening, and less than 15% would extend the screening interval when using the Papanicolaou test and human papillomavirus (HPV) test together, as some guidelines suggest.

18 Aug 2011

Researchers isolate 17 novel antibodies against HIV

A team of researchers at and associated with the International AIDS Vaccine Initiative (IAVI), The Scripps Research Institute, the biotechnology company Theraclone Sciences and Monogram Biosciences Inc., a LabCorp company, report in the current issue of Nature the isolation of 17 novel antibodies capable of neutralizing a broad spectrum of variants of HIV, the virus that causes AIDS.

18 Aug 2011

Unexplained hospital factors have impact on radioactive iodine use for thyroid cancer: Study

Where thyroid cancer patients go for care plays a large role in whether they receive radioactive iodine treatment, a new study from the University of Michigan Comprehensive Cancer Center finds.

18 Aug 2011

Scientists turn drug-disease match makers

In a new medical breakthrough American researchers have devised a drug-disease matchmaking program that mines databases for potentially useful new treatment combinations and have actually turned up two so far, said a study on Wednesday.

18 Aug 2011